Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compounds targeting PMP22 for the treatment of Charcot-Marie-Tooth disease

Compounds targeting PMP22 for the treatment of Charcot-Marie-Tooth disease

US Patent 12497616 · Granted Dec 16, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Galnac conjugated modified oligonucleotides as miR-122 inhibitor having HCV anti2024
Compositions comprising alternating 2′-modified nucleosides for use in gene modu2021
Compositions comprising alternating 2′-modified nucleosides for use in gene modu2019
Compositions comprising alternating 2′-modified nucleosides for use in gene modu2017
5′-substituted bicyclic nucleosides and oligomeric compounds prepared therefrom2015
Compositions comprising alternating 2′-modified nucleosides for use in gene modu2015
Compositions comprising alternating 2'-modified nucleosides for use in gene modu2015
Tetrahydropyran nucleic acid analogs2015
Tetrahydropyran nucleic acid analogs2014
Base modified bicyclic nucleosides and oligomeric compounds prepared therefrom2014
Compositions comprising alternating 2′-modified nucleosides for use in gene modu2013
Tetrahydropyran nucleic acid analogs2013